Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2259031

Cc1cc(C)c(-[n+]2ccc(-c3cc[n+](C(c4ccccc4)P(=O)(O)O)cc3)cc2)c(C)c1.[Cl-].[Cl-]

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 known ✓ P23975 2/20 0.32
▸ SLC6A3 known ✓ Q01959 2/20 0.32
▸ ACP3 P15309 10/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ SRC P12931 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ SLC6A4 P31645 2/20 0.32
▸ MMP8 P22894 1/20 0.31
▸ MMP14 P50281 1/20 0.31
▸ CA14 Q9ULX7 1/20 0.31
▸ FDPS P14324 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2899630 0.90 ACP3 (0.43) ACP3SMN1; SMN2SRCKDM4EALDH1A1
Hydrochloric Acid SCHEMBL2892897 0.86 ACP3 (0.39) ACP3SMN1; SMN2SRCKDM4EALDH1A1
Hydrochloric Acid SCHEMBL2259577 0.82 ACP3 (0.38) ACP3SMN1; SMN2MEN1KMT2ASRC
Hydrochloric Acid SCHEMBL2258996 0.81 FDPS (0.32) SMN1; SMN2KDM4EALDH1A1LMNAHTT
Hydrochloric Acid SCHEMBL2264057 0.80 ACP3 (0.41) ACP3SRCMMP8MMP14CA14
SCHEMBL5565745 0.79 KDM4E (0.31) SMN1; SMN2KDM4EALDH1A1LMNAHTT
Hydrochloric Acid SCHEMBL3928802 0.78 ACP3 (0.41) ACP3SMN1; SMN2SRCKDM4EALDH1A1
Hydrochloric Acid SCHEMBL2264240 0.75 ACP3 (0.37) ACP3SRCKDM4EMMP8MMP14
Hydrochloric Acid SCHEMBL2469452 0.73 RAB9A (0.33) SMN1; SMN2KDM4EALDH1A1LMNAHTT
Hydrochloric Acid SCHEMBL604501 0.73 PGK1 (0.38) ACP3SMN1; SMN2LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060110638-A1 Electrochromic compounds NTERA LIMITED (IE) 2006-05-25 — — US claimed
EP-1594938-A1 ELECTROCHROMIC COMPOUNDS Ntera Limited (IE) 2005-11-16 — — EP claimed
WO-2004067673-A1 ELECTROCHROMIC COMPOUNDS NTERA LIMITED (IE) 2004-08-12 — — WO claimed
EP-1443091-A1 Electrochromic compounds Ntera Limited (IE) 2004-08-04 — — EP claimed
US-8999430-B2 Method of manufacturing display element KONICA MINOLTA HOLDINGS, INC. (JP) 2015-04-07 — — US disclosed
EP-2149816-B1 METHOD OF MANUFACTURING AN ELECTROCHROMIC DISPLAY ELEMENT KONICA MINOLTA HOLDINGS INC (JP) 2014-05-07 — — EP disclosed
US-8014056-B2 Display element and method of driving the same KONICA MINOLTA HOLDINGS, INC. (JP) 2011-09-06 — — US disclosed
US-8004742-B2 Electrochromic display device KONICA MINOLTA HOLDINGS, INC. (JP) 2011-08-23 — — US disclosed
US-20100166946-A1 METHOD OF MANUFACTURING DISPLAY ELEMENT KONICA MINOLTA HOLDINGS, INC. (JP) 2010-07-01 — — US disclosed
US-20100091353-A1 DISPLAY ELEMENT AND METHOD OF DRIVING THE SAME KONICA MINOLTA HOLDINGS, INC. (JP) 2010-04-15 — — US disclosed
EP-2149816-A1 METHOD FOR PRODUCTION OF DISPLAY ELEMENT Konica Minolta Holdings, Inc. (JP) 2010-02-03 — — EP disclosed
US-20090316249-A1 ELECTROCHROMIC DISPLAY DEVICE KONICA MINOLTA HOLDINGS, INC. (JP) 2009-12-24 — — US disclosed
US-20090259042-A1 ELECTROCHROMIC COMPOUNDS NTERA LIMITED (IE) 2009-10-15 — — US disclosed
EP-2096490-A1 DISPLAY ELEMENT AND METHOD OF DRIVING THE SAME Konica Minolta Holdings, Inc. (JP) 2009-09-02 — — EP disclosed
US-7567371-B2 Electrochromic compounds NTERA LIMITED (IE) 2009-07-28 — — US disclosed
EP-2040115-A1 ELECTROCHROMIC DISPLAY DEVICE Konica Minolta Holdings, Inc. (JP) 2009-03-25 — — EP disclosed
US-20060110638-A1 Electrochromic compounds NTERA LIMITED (IE) 2006-05-25 — — US disclosed
EP-1594938-A1 ELECTROCHROMIC COMPOUNDS Ntera Limited (IE) 2005-11-16 — — EP disclosed
WO-2004067673-A1 ELECTROCHROMIC COMPOUNDS NTERA LIMITED (IE) 2004-08-12 — — WO disclosed
EP-1443091-A1 Electrochromic compounds Ntera Limited (IE) 2004-08-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090259042-A1 ELECTROCHROMIC COMPOUNDS ETV6, HCN2, EED SLC6A2 1509/4885SLC6A3 1961/4885ACP3 2868/4885
US-20060110638-A1 Electrochromic compounds ETV6, HCN2, EED SLC6A2 1509/4885SLC6A3 1961/4885ACP3 2868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback